Maki Etori

The authors state no conflict of interest.

M. Yamashita, H. Karasuyama, H. Maeda, 2012 .

A novel CC chemokine receptor 4 antagonist RS-1269 inhibits ovalbumin-induced ear swelling and lipopolysaccharide-induced endotoxic shock in mice.

M. Yamashita, Y. Nakagami, F. Nara, 2010, Basic & clinical pharmacology & toxicology.

Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells.

K. Hirokawa, M. Yamashita, H. Yonekawa, 2005, Immunity.

Evaluation of the therapeutic index of a novel phosphodiesterase 4B-selective inhibitor over phosphodiesterase 4D in mice.

Satoshi Nakamura, T. Mikkaichi, H. Maeda, 2013, Journal of pharmacological sciences.

Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors.

Mizuki Takahashi, S. Sasaki, T. Mikkaichi, 2014, Bioorganic & medicinal chemistry letters.

Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice.

M. Yamashita, Y. Nakagami, S. Miyazaki, 2009, European journal of pharmacology.

RS-1748, a novel CC chemokine receptor 4 antagonist, inhibits ovalbumin-induced airway inflammation in guinea pigs.

M. Yamashita, T. Fukuda, Y. Nakagami, 2010, Biological & pharmaceutical bulletin.

Melanocortin receptors 1 and 5 might mediate inhibitory effects of α-melanocyte-stimulating hormone on antigen-induced chronic allergic skin inflammation in IgE transgenic mice.

M. Yamashita, H. Karasuyama, H. Maeda, 2012, The Journal of investigative dermatology.